Immuneel Therapeutics Private Limited

Immuneel Therapeutics Private Limited - healthcare in Bengaluru, Karnataka, India. FY 2026 financials and compliance.
CIN U24230KA2018PTC119691 Incorporated 20 December 2018 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2024
₹2.25 Cr
▼ 47.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹100 Cr
Registered with MCA
Paid-up capital
₹4.64 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
96
Latest available

About Immuneel Therapeutics Private Limited

Data last updated: 14 December 2025

Immuneel Therapeutics Private Limited is a private limited company based in Bengaluru, Karnataka, India, recognised as a startup by DPIIT. It specialises in oncology clinics and cancer treatment, a part of the broader healthcare sector. Incorporated on 20 December 2018, the company has been in operation for over 8 years.

Registered with ROC Bangalore under CIN U24230KA2018PTC119691.

Capital: an authorised share capital of ₹100 Cr and a paid-up capital of ₹4.64 Lakh. It is led by directors including Kiran Mazumdar Shaw and Siddhartha Mukherjee.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 29/P2 8Th Floor Narayana Health City Hosur Road Bommasandra Industrial Area, Bengaluru, Karnataka, India – 560099.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.25 Cr, a decline of 47% compared to the previous year.

The company has a workforce of approximately 96 employees as per the latest available data.

The company is associated with 1 brand - Immuneel.

For more details, the company can be reached via its website immuneel.com.

Company Details of Immuneel Therapeutics Private Limited
CIN U24230KA2018PTC119691
Registration Number 119691
Incorporation Date 20 December 2018
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    29/P2 8Th Floor Narayana Health City Hosur Road Bommasandra Industrial Area, Bengaluru, Karnataka, India – 560099
  • Industry
    Healthcare, Oncology Clinics & Cancer Treatment
Company report
Immuneel Therapeutics Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Immuneel Therapeutics Private Limited report

Financials, compliance, directors, charges, ownership and filings for Immuneel Therapeutics Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Immuneel Therapeutics Private Limited

Immuneel Therapeutics Private Limited operates one associated brand: Immuneel. These brands represent Immuneel Therapeutics Private Limited's diversified market presence and brand portfolio.

Brand Description Website
T-cell therapies for cancer treatment are developed using genetic engineering. immuneel.com

Competitors & Alternatives of Immuneel Therapeutics Private Limited

Brands and companies operating in the same space as Immuneel Therapeutics Private Limited include Moderna, Jazz Pharmaceuticals, Advanced Accelerator Applications and 6 more.

Competitor Description Location Founded
Moderna Moderna mRNA-based therapeutics for diseases including cancer and infections are developed. Cambridge, United States, United States 2010
Jazz Pharmaceuticals Jazz Pharmaceuticals Novel biopharmaceutical medicines are developed for unmet medical needs. Dublin, Ireland, Ireland 2003
Advanced Accelerator Applications Advanced Accelerator Applications Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. Saint Genis Pouilly, France, France 2002
C4 Therapeutics C4 Therapeutics Small-molecule drugs for cancer treatment are developed via Degronimid platform. Cambridge, United States, United States 2016
BeiGene BeiGene Targeted and immune-oncology drugs for cancer treatment are developed. Cambridge, United States, United States 2010
Syndax Syndax Targeted therapies for cancer treatment are developed. Waltham, United States, United States 2005
Revolution Medicines Revolution Medicines Cancer therapies are developed using selective pathway inhibitors. Redwood City, United States, United States 2014
Blueprint Medicines Blueprint Medicines Selective kinase inhibitors are developed for genomically defined cancers. Cambridge, United States, United States 2008
Incyte Incyte Small molecules are developed for cancer and skin disease treatments. Wilmington, United States, United States 1991

Business Activity of Immuneel Therapeutics Private Limited

Immuneel Therapeutics Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Immuneel Therapeutics Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Immuneel Therapeutics Private Limited

Immuneel Therapeutics Private Limited is audited by S.R. BATLIBOI & ASSOCIATES LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S.R. BATLIBOI & ASSOCIATES LLP Locked Locked Locked
Premium access

Complete auditor history for Immuneel Therapeutics Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Immuneel Therapeutics Private Limited

Immuneel Therapeutics Private Limited is currently managed by 6 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Kiran Mazumdar Shaw Director 20 Dec 2018 7 Years 7 Months Current
Siddhartha Mukherjee Director 20 Apr 2022 4 Years 3 Months Current
Prem Venkatachalam Pavoor Director 20 Apr 2022 4 Years 3 Months Current
Ranjan Ramdas Pai Director 20 Dec 2018 7 Years 7 Months Current
Amit Mookim Director 06 Sep 2024 1 Years 10 Months Current
Saif Khalfan Mohamed Al Hasani Director 29 Aug 2024 1 Years 10 Months Current

Financials of Immuneel Therapeutics Private Limited FY 2024 filings available

Immuneel Therapeutics Private Limited reported revenue of ₹2.25 Cr (down 47.00% YoY) for FY 2024.

Revenue · FY 2024
₹2.25 Cr ▼ 47.00%
Premium access

Ten-year financial statements for Immuneel Therapeutics Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Immuneel Therapeutics Private Limited

Premium access

Shareholding and ownership data for Immuneel Therapeutics Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Immuneel Therapeutics Private Limited

Immuneel Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Immuneel Therapeutics Private Limited

Immuneel Therapeutics Private Limited has a workforce of 96 employees as of Apr 06, 2024.

Employee count
96
Active EPFO establishments
1
Employee growth
52.38%
Premium access

Employee and EPFO history for Immuneel Therapeutics Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Immuneel Therapeutics Private Limited

Premium access

GST registrations and filing compliance for Immuneel Therapeutics Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Immuneel Therapeutics Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Immuneel Therapeutics Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Immuneel Therapeutics Private Limited

Premium access

MSME payment history for Immuneel Therapeutics Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Immuneel Therapeutics Private Limited

Premium access

Corporate group structure for Immuneel Therapeutics Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Immuneel Therapeutics Private Limited

Premium access

MCA filings and documents for Immuneel Therapeutics Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Immuneel Therapeutics Private Limited

Activity
30 Sep 2024
Immuneel Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Directors
06 Sep 2024
Amit Mookim was appointed as a Director on 06 Sep 2024 & has been associated with this company since 1 year 10 months.
Directors
29 Aug 2024
Saif Khalfan Mohamed Al Hasani was appointed as a Director on 29 Aug 2024 & has been associated with this company since 1 year 10 months.
Activity
31 Mar 2024
Immuneel Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Directors
20 Apr 2022
Siddhartha Mukherjee was appointed as a Director on 20 Apr 2022 & has been associated with this company since 4 years 3 months.
Directors
20 Apr 2022
Prem Venkatachalam Pavoor was appointed as a Director on 20 Apr 2022 & has been associated with this company since 4 years 3 months.

Frequently Asked Questions about Immuneel Therapeutics Private Limited

Immuneel Therapeutics Private Limited is an active private limited company in the healthcare sector based in Bengaluru, Karnataka, India. It was incorporated on 20 December 2018 (8+ years old) and is registered under CIN U24230KA2018PTC119691. The company has 96 employees.

Immuneel Therapeutics Private Limited reported revenue of ₹2.25 Cr for FY 2024 (down 47.00% YoY).

The current directors of Immuneel Therapeutics Private Limited are:

The primary industry of Immuneel Therapeutics Private Limited is healthcare. The company specifically operates in oncology clinics and cancer treatment. The company is currently active in this sector.

Yes, Immuneel Therapeutics Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Immuneel Therapeutics Private Limited can be reached at the registered office: 29P2 8Th Floor Narayana Health City Hosur Road Bommasandra Industrial Area, Bengaluru, Karnataka, India – 560099, or through the website immuneel.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available